Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

GSK plc announced the marketing authorisation of Exdensur (depemokimab) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Exdensur is now approved in two indications: ...

This article first appeared on GuruFocus. Analysts are increasingly focusing on GSK (NYSE:GSK) after Europe's drug regulator delivered what could be a pivotal endorsement for depemokimab, a treatment ...

A digital, noninvasive home‑monitoring system — integrating home spirometry, smartwatch data, and medical feedback — showed promise for managing pediatric asthma. Nocturnal heart rate monitoring was ...